About Longdom Conferences
Longdom Conferences hosts 200+ leading international conferences and virtual events annually. It is instrumental in bringing together experts and learners from all over the globe for mutual growth and effective research-oriented discussions. As per the present market demand and growth in the field of Ophthalmology Eye Care research, Longdom Meetings is hosting its "Eye Conference 2025 ," This will be one of the leading surgery conferences scheduled for scheduled for Jan 06-07 |Tokoyo, Japan. The event will revolve around the theme, "Screening to Intervention: Innovations in Comprehensive Eye Care". The scope of Ophthalmology Eye Care encompasses various aspects of healthcare, including but not limited to hand hygiene, surgical site infections, eye safety, antimicrobial resistance, and operational protocols for hospitals during both routine operations and emergencies.
Why join LONGDOM conferences?
Understand the current state of research | Meet international colleagues and experts | Visit the exhibition of leading-edge technology | Engage with editors of the top journals in your field | Global networking and certification | Brand Launching and many more to explore
Why you should attend?
Engage in the instigative event format, with round tables, panels, exhibits, speed networking, and multiple conference tracks.
Share gests perceptivity and strategies in interactive peer-to-peer round tables.
Hear further perspectives in one place – from large medium and small organizations from pharma, biotech, and academia.
Benefits of attending:
Networking Opportunities, Grow Your Professional Network
Build Your Knowledge Base
Expand Your Resources
Meet Experts & Influencers Face to Face
Learning In a New Space
Break Out of Your Comfort Zone
New Tips & Tactics
Greater Focus
The Serendipity of the Random Workshop
Preconference Workshops in all major countries
Remarkable Awards and Global Recognition to meritorious Researchers
Nominations for Best Poster Award
Group Registration benefits
Advanced-oriented presentations
Collaborations across Academia & Industry
Target Audience: The target audience is Physicians, Licensed Practical Nurses, Industry Professionals, Research Scholars, Healthcare Professionals Diagnostic laboratory professionals, Business Entrepreneurs, Directors & Ceo’s of Organizations, Hospitals, Microbiologists, Pharmaceutical Industries, and Nurse Practitioners.
Sessions:
Ophthalmology, Vision Science:
Ophthalmology is the medical field focused on diagnosing and treating eye disorders. Ophthalmologists are experts in both medical and surgical eye care, addressing various eye conditions and visual impairments. They can also detect signs of systemic diseases through eye examinations, ensuring timely referrals for further treatment.
Vision science is an interdisciplinary field that studies visual systems and perception, integrating ophthalmology, optometry, molecular genetics, neurology, and optics. It explores the anatomy, biochemistry, and physiology of the eye, forming the basis for research on human vision, visual impairments, and potential treatments.
Clinical & Experimental Ophthalmology:
CRISPR and Gene Editing in Ophthalmology: Examine the potential of CRISPR and other gene-editing technologies in treating inherited retinal diseases, focusing on recent breakthroughs and ethical considerations in clinical applications.
Artificial Intelligence in Early Diagnosis of Ocular Diseases: Discuss the integration of AI and machine learning in the early detection of eye conditions such as glaucoma, macular degeneration, and diabetic retinopathy, and its impact on improving patient outcomes.
Disorders of Cataract, Sclera, Cornea, Glaucoma and Eye Tumours:
Cataract:
Disorder: Posterior Capsule Opacification (PCO)
Latest Example: Development of femtosecond laser-assisted posterior capsulotomy to treat PCO more precisely and reduce recurrence rates.
Scleral Disorders:
Disorder: Scleral Ectasia
Example: Use of collagen cross-linking in the sclera to treat progressive scleral ectasia, providing structural reinforcement and slowing disease progression.
Corneal Disorders
Disorder: Keratoconus
Example: Introduction of epi-on corneal cross-linking as a less invasive treatment for keratoconus, improving patient comfort and recovery times compared to traditional methods.
Glaucoma
Disorder: Normal-Tension Glaucoma (NTG): Exploration of Selective Laser Trabeculoplasty (SLT) as a primary treatment for NTG, offering a non-invasive option with promising intraocular pressure control.
Eye Tumors
Disorder: Uveal Melanoma Latest Example: Implementation of Proton Beam Therapy as a targeted treatment for uveal melanoma, providing precise radiation delivery with reduced damage to surrounding ocular tissues.
Ocular Immunology and Microbiology:
Ocular Immunology:
Advances in Understanding and Treating Uveitis: This session focuses on the latest research into the pathophysiology of uveitis, including the role of immune system dysfunction. It will cover recent advances in diagnostic techniques and treatment options, including novel immunosuppressive therapies and biologics.
Microbiology:
Emerging Trends in Antimicrobial Resistance: This session addresses the rising issue of antimicrobial resistance, highlighting recent trends and research. Topics include the genetic mechanisms of resistance, the impact on clinical practice, and new strategies for combating resistant strains through alternative therapies and drug development.
Eye Surgeries and Major Ophthalmologic Surgery:
Eye Surgeries:
Advancements in Cataract Surgery Techniques: This session explores the latest innovations in cataract surgery, including new surgical techniques, intraocular lenses, and postoperative management. It often includes live demonstrations or video presentations of advanced cataract procedures.
Major Ophthalmologic Surgery:
Innovations in Retinal Surgery: From Vitrectomy to Advanced Retinal Implants: Focuses on cutting-edge developments in retinal surgery, including the use of vitreoretinal surgery techniques and the integration of advanced retinal implants. Discussions often cover recent research, clinical outcomes, and future directions in retinal surgical interventions.
Ophthalmogenetics ,Gene Therapy and Orthokeratology:
Ophthalmogenetics:
Genetic Basis and Emerging Therapies for Inherited Retinal Diseases :This session delves into the genetic mutations responsible for inherited retinal diseases, such as retinitis pigmentosa and Stargardt disease. It highlights recent advancements in genetic testing, the role of gene editing technologies, and new therapeutic approaches, including gene therapy and personalized medicine.
Gene Therapy:
Gene Therapy for Ocular Diseases: Current Strategies and Future Directions: Focuses on the application of gene therapy to treat ocular diseases, including techniques for delivering therapeutic genes to the retina and cornea. The session covers recent clinical trials, challenges in gene delivery, and the potential for gene therapy to address conditions like Leber congenital amaurosis and age-related macular degeneration.
Orthokeratology:
Innovations and Clinical Outcomes in Orthokeratology for Myopia Control: Examines the latest advancements in orthokeratology (Ortho-K) lenses used for myopia management. The session reviews new lens designs, clinical effectiveness, patient selection criteria, and long-term outcomes of Ortho-K treatment for controlling myopia progression in children and adults.
Ocular Oncology,Cornea and External Diseases and Eye Conditions Treatments:
Current Strategies in Ocular Oncology: From Diagnosis to Treatment:
This session reviews recent advancements in the diagnosis and management of ocular tumors, such as uveal melanoma and retinoblastoma. It includes discussions on cutting-edge diagnostic tools, innovative treatment modalities, and the integration of multidisciplinary approaches in patient care.
Cornea and External Diseases:
Advancements in Corneal Disease Management and Treatment
Focuses on the latest innovations in diagnosing and treating corneal diseases, including keratoconus, corneal dystrophies, and infections. It covers new surgical techniques, therapeutic options, and advancements in corneal transplantation.
Nano Ophthalmology, Neuro-Ophthalmology:
Nanotechnology Innovations in Ophthalmology: From Drug Delivery to Diagnostics"
This session explores the application of nanotechnology in ophthalmology, including advances in nanoparticle-based drug delivery systems, diagnostic imaging, and therapeutic interventions for various ocular diseases. It covers recent research, clinical applications, and the future potential of nanotechnology in eye care.
Advancements in Neuro-Ophthalmology: Diagnosing and Managing Neurological Eye Disorders:
Focuses on the latest developments in neuro-ophthalmology, including diagnostic techniques and treatment strategies for conditions affecting both the visual system and the nervous system. Topics include optic neuritis, stroke-related visual disturbances, and the management of complex neurological disorders impacting vision.
Advanced Ophthalmological Care and Ophthalmic Healthcare:
Advanced Ophthalmological Care
Cutting-Edge Techniques in Advanced Ophthalmological Care: Examines the latest advancements in high-complexity eye care, including state-of-the-art surgical techniques, innovative diagnostic tools, and novel therapeutic approaches for complex ocular conditions.
Ophthalmic Healthcare:
Enhancing Patient Outcomes in Ophthalmic Healthcare: Best Practices and Innovations: Focuses on strategies for improving patient care in ophthalmology, covering new protocols, patient management techniques, and innovative solutions to enhance overall healthcare delivery and patient outcomes in eye care.